The World Health Organization Regional Office for Europe. The Multi-Country Antimicrobial Resistance Workshop (24–27 February 2015, Copenhagen, Denmark)
Antimicrobial resistance (AMR) is recognized as one of the major health threats of our time. Addressing this complex public health problem requires action in all relevant sectors, including human health, veterinary health, agriculture, environment and education to preserve the effectiveness of antibiotics by discouraging their misuse and overuse, and by gathering data to track resistance and usage patterns.
The 2011 European strategic action plan on antibiotic resistance (EUR/RC61/14) outlined seven strategic objectives in a comprehensive response to AMR. Since then the Regional Office has provided targeted assistance to Member States, building capacity to address the challenges posed by AMR.
Continuing to deliver on the objectives of the action plan, the Regional Office invited delegates from 17 countries to participate in eight programmes aimed at providing targeted input, and creating a unique opportunity to share experiences for the different participant profiles, including microbiologists, epidemiologists, pharmacists and clinicians.
The Multi-Country Antimicrobial Resistance Workshop was held on 24–27 February 2015 at the United Nations City in Copenhagen, Denmark. Ukraine also took part in the workshop, represented by Aidyn Salmanov, MD, Dr. Sc., Professor, National coordinator of Antimicrobial Resistance (AMR focal point) and Infection Control, Head of the Department of Microbiology and Epidemiology of Shupyk National Medical Academy of postgraduate education, Olga Golubovska, MD, Dr. Sc., Professor (Department of Infectious Diseases of Bogomolets National Medical University), Dr. Tetiana Glushrtvych (Bacteriological Laboratory State Institution Ukrainian Center of Diseases Control and Monitoring) and Larisa Iakovleva MD, Dr. Sc., Professor, (National Pharmaceutical University)
The meeting was co-hosted by the Control of Antimicrobial Resistance and Health Technologies and Pharmaceuticals (HTP) programs of the WHO Regional Office for Europe.
Leave a comment